RT Journal Article
SR Electronic
T1 Neonatologists are using much less dexamethasone
JF Archives of Disease in Childhood - Fetal and Neonatal Edition
JO Arch Dis Child Fetal Neonatal Ed
FD BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health
SP F432
OP F433
DO 10.1136/fn.88.5.F432
VO 88
IS 5
A1 E S Shinwell
A1 M Karplus
A1 D Bader
A1 S Dollberg
A1 I Gur
A1 Z Weintraub
A1 S Arnon
A1 E Gottfreid
A1 A Zaritsky
A1 I R Makhoul
A1 D Reich
A1 L Sirota
A1 I Berger
A1 A Kogan
A1 S Yurman
A1 M Goldberg
A1 D Kohelet
YR 2003
UL http://fn.bmj.com/content/88/5/F432.abstract
AB Two historical cohorts (1993–1994 and 2001) of preterm infants ventilated for respiratory distress syndrome were compared. Dexamethasone administration fell from 22% to 6%. Chronic lung disease in survivors rose slightly from 13% to 17%, and mortality fell from 21% to 15% (other causes). The effect of restriction of dexamethasone use on chronic lung disease and mortality remains to be seen.